Regulatory Affairs
Streamlining Your Journey Through Regulatory Landscapes
We empower compliance and ensure highest quality standards by our end-to-end regulatory affairs services.
At Zenovel, we are dedicated to providing clients with the necessary knowledge and tools to navigate the regulatory landscape, ensuring compliance, improving product quality, and achieving business objectives.
Zenovel provides comprehensive Regulatory Services to streamline the approval process and ensure global compliance. Our team of experts collaborates with clients to provide tailored solutions, addressing regulatory challenges from early development to post-marketing surveillance.
- Our Regulatory Affairs Services includes
- Why Choose Zenovel ?
- Expert Support
Our experienced and knowledgeable team assure your submission meets highest regulatory standards.
- Global Network
We support your product’s compliance in multiple markets and help to expand your reach and achieve global success.
- Personalized Solution
- Continuous Support
We provide from initial consultation to post-approval maintenance.
People Also Ask (FAQs)
Regulatory Affairs in the pharmaceutical industry is a specialized function responsible for ensuring that pharmaceutical, biotechnology, and medical device products comply with global regulatory requirements. Regulatory Affairs services involve preparing regulatory submissions, managing communications with health authorities, and maintaining pharmaceutical regulatory compliance throughout the product lifecycle from development to post-marketing.
Zenovel prepares and manages high-quality regulatory submissions, including CTD, eCTD, and dossier compilation. They ensure accurate documentation and timely submission to global regulatory authorities.
A complete regulatory submission typically includes documentation prepared in CTD or eCTD format, such as the Investigational New Drug (IND) application, New Drug Application (NDA), or Marketing Authorization Application (MAA). It also includes clinical study reports, stability data, CMC documentation, and risk management plans. Professional regulatory submission services ensure these documents are accurate, well-structured, and compliant with regulatory guidelines.
The electronic Common Technical Document (eCTD) is the standardized electronic format used for regulatory submissions in the pharmaceutical industry. Authorities such as the US FDA and EMA require eCTD submission services because the format improves regulatory review efficiency, enables lifecycle management of submissions, and supports faster communication between pharmaceutical companies and regulatory agencies.
Zenovel ensures accuracy, compliance, and audit readiness by following global regulatory guidelines and maintaining high-quality standards in every submission.
Blogs and news
Our Latest Article
Introduction to Generic Inhalation Product Development Inhalation products pose significant challenges in generic drug development due to the complexity of formulations and device technology, making bioequivalence more difficult to establish compared to conventional oral dosage forms. Examples include Albuterol MDIs (metered dose inhalers), DPIs Dry Powder Inhalers, and nebulized therapies,
India is a significant player in the global pharmaceuticals sector, characterized by a diverse population and cost-effective infrastructure. However, its potential in clinical research is hindered by complex regulatory challenges that delay innovations and deter investment, affecting the timely market introduction of life-saving drugs. This blog discusses the major obstacles
The FDA issued 466 Form 483s to drug organizations in FY 2022, more than double the previous year, highlighting significant quality failures in the pharmaceutical sector. For startups and scale-ups seeking market approval, the excitement of innovation often conflicts with the strict requirements of current good manufacturing practices (cGMP). Although
Introduction Liposomal Amphotericin-B is a critical antifungal medication that requires careful attention during Bioequivalence (BE) studies. These studies aim to demonstrate the similarity of a generic liposomal Amphotericin B formulation to the reference drug in terms of pharmacokinetics. Zenovel, with its extensive experience in monitoring Amphotericin B studies, can play
In the pharmaceutical and biotechnology industries, obtaining regulatory approval is essential prior to introducing new drugs or biologics to the market. A pivotal aspect of this approval process is the FDA Pre-Approval Inspection (PAI), which involves a comprehensive assessment of manufacturing facilities, processes, and data integrity to ensure adherence to
Risk Based Monitoring (RBM) is a more efficient alternative to traditional clinical trials, focusing on high-risk areas through data-driven insights. It ensures patient safety, data integrity, and regulatory compliance while reducing costs and timelines. However, the success of RBM depends on the competency of monitors, who identify risks, analyze data,
